CoChat
Sign Up
Cited by 119Neonatal and fetal brain pathologyNeuroinflammation and Neurodegeneration MechanismsTraumatic Brain Injury and Neurovascular Disturbances

The DOI matches its Crossref record; 70 of the 72 references it cites were found in a registry or an index.

JNK signaling is the shared pathway linking neuroinflammation, blood-brain barrier disruption and oligodendroglial apoptosis in the white matter injury of the immature brain

Open access
Wang, Lan-Wan, Tu, Yi-Fang, Huang, Chao-Ching, Ho, Chien-Jung·2012·Journal of Neuroinflammation
DOI 10.1186/1742-2094-9-175PMC PMC3414763
Open this paper in CoChat — free accountOpen PDF

Abstract

BACKGROUND: White matter injury is the major form of brain damage in very preterm infants. Selective white matter injury in the immature brain can be induced by lipopolysaccharide (LPS)-sensitized hypoxic-ischemia (HI) in the postpartum (P) day 2 rat pups whose brain maturation status is equivalent to that in preterm infants less than 30 weeks of gestation. Neuroinflammation, blood-brain barrier (BBB) damage and oligodendrocyte progenitor apoptosis may affect the susceptibility of LPS-sensitized HI in white matter injury. c-Jun N-terminal kinases (JNK) are important stress-responsive kinases in various forms of insults. We hypothesized that LPS-sensitized HI causes white matter injury through JNK activation-mediated neuroinflammation, BBB leakage and oligodendroglial apoptosis in the white matter of P2 rat pups. METHODS: P2 pups received LPS (0.05 mg/kg) or normal saline injection followed by 90-min HI. Immunohistochemistry and immunoblotting were used to determine microglia activation, TNF-α, BBB damage, cleaved caspase-3, JNK and phospho-JNK (p-JNK), myelin basic protein (MBP), and glial fibrillary acidic protein (GFAP) expression. Immunofluorescence was performed to determine the cellular distribution of p-JNK. Pharmacological and genetic approaches were used to inhibit JNK activity. RESULTS: P2 pups had selective white matter injury associated with upregulation of activated microglia, TNF-α, IgG extravasation and oligodendroglial progenitor apoptosis after LPS-sensitized HI. Immunohistochemical analyses showed early and sustained JNK activation in the white matter at 6 and 24 h post-insult. Immunofluorescence demonstrated upregulation of p-JNK in activated microglia, vascular endothelial cells and oligodendrocyte progenitors, and also showed perivascular aggregation of p-JNK-positive cells around the vessels 24 h post-insult. JNK inhibition by AS601245 or by antisense oligodeoxynucleotides (ODN) significantly reduced microglial activation, TNF-α immunoreactivity, IgG extravasation, and cleaved caspase-3 in the endothelial cells and oligodendrocyte progenitors, and also attenuated perivascular aggregation of p-JNK-positive cells 24 h post-insult. The AS601245 or JNK antisense ODN group had significantly increased MBP and decreased GFAP expression in the white matter on P11 than the vehicle or scrambled ODN group. CONCLUSIONS: LPS-sensitized HI causes white matter injury through JNK activation-mediated upregulation of neuroinflammation, BBB leakage and oligodendrocyte progenitor apoptosis in the immature brain.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1742-2094-9-175

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Upregulation of neuroinflammation, blood–brain barrier damage and cell apoptosis in association with white matter injury in P2 rat pups after lipopolysaccharide-sensitized hypoxic-ischemia. On P11 in the LPS + HI group, Nissl staining (A) showed no significant injury in the cortex (gross picture in the upper panel; microscopic picture in the lower panel photographed from the cortex marked with an asterisk). (B) Immunohistochemical staining demonstrated that the LPS + HI group had markedly decreased MBP expression and increased GFAP-positive astrogliosis in the white matter of the ipsilateral hemisphere compared to the control and NS + HI groups. (C) Immunohistochemistry 24 h post-insult showed that the LPS + HI but not the NS + HI group had significant increases in ED1-positive microglia, TNF-α immunoreactivities, IgG extravasation, and cleaved caspase 3-positive apoptotic cells in the white matter. Microscopic pictures of (B,C) were taken from the white matter area marked with a circle in (A). ED1, microglia marker; GFAP, glial fibrillary acidic protein; HI, hypoxic-ischemia; LPS, lipopolysaccharide; MBP, myelin basic protein; NS, normal saline; P, postpartum. Scale bar = 200 μm for MBP, 50 μm for cleaved caspase 3, and 100 μm for the others.
Figure 1 Upregulation of neuroinflammation, blood–brain barrier damage and cell apoptosis in association with white matter injury in P2 rat pups after lipopolysaccharide-sensitized hypoxic-ischemia. On P11 in the LPS + HI group, Nissl staining (A) showed no significant injury in the cortex (gross picture in the upper panel; microscopic picture in the lower panel photographed from the cortex marked with an asterisk). (B) Immunohistochemical staining demonstrated that the LPS + HI group had markedly decreased MBP expression and increased GFAP-positive astrogliosis in the white matter of the ipsilateral hemisphere compared to the control and NS + HI groups. (C) Immunohistochemistry 24 h post-insult showed that the LPS + HI but not the NS + HI group had significant increases in ED1-positive microglia, TNF-α immunoreactivities, IgG extravasation, and cleaved caspase 3-positive apoptotic cells in the white matter. Microscopic pictures of (B,C) were taken from the white matter area marked with a circle in (A). ED1, microglia marker; GFAP, glial fibrillary acidic protein; HI, hypoxic-ischemia; LPS, lipopolysaccharide; MBP, myelin basic protein; NS, normal saline; P, postpartum. Scale bar = 200 μm for MBP, 50 μm for cleaved caspase 3, and 100 μm for the others.CC BY · PubMed Central
Figure 2 Upregulation of JNK activation in lipopolysaccharide-sensitized hypoxic-ischemic white matter injury. (A) Immunoblotting of white matter in the lipopolysaccharide (LPS) + hypoxic-ischemic (HI) group showed there was an early rise of phospho-c-Jun N-terminal kinase (p-JNK) expression at 1 h, which peaked at 6 h and persisted at 24 h post-insult. The JNK expression did not differ between the control and LPS + HI groups at various time points post-insult. (B) p-JNK immunohistochemistry at 6 and 24 h post-insult showed the LPS + HI group (n = 10) had significantly higher p-JNK immunoreactivities in the white matter of the ipsilateral hemisphere than the control (n = 7) groups. Scale bar =100 μm in (B). Values are means ± SEM. ***P < 0.001, **P < 0.01.
Figure 2 Upregulation of JNK activation in lipopolysaccharide-sensitized hypoxic-ischemic white matter injury. (A) Immunoblotting of white matter in the lipopolysaccharide (LPS) + hypoxic-ischemic (HI) group showed there was an early rise of phospho-c-Jun N-terminal kinase (p-JNK) expression at 1 h, which peaked at 6 h and persisted at 24 h post-insult. The JNK expression did not differ between the control and LPS + HI groups at various time points post-insult. (B) p-JNK immunohistochemistry at 6 and 24 h post-insult showed the LPS + HI group (n = 10) had significantly higher p-JNK immunoreactivities in the white matter of the ipsilateral hemisphere than the control (n = 7) groups. Scale bar =100 μm in (B). Values are means ± SEM. ***P < 0.001, **P < 0.01.CC BY · PubMed Central
Figure 3 JNK activation in microglia, vascular endothelial cells and oligodendrocyte progenitors at 6 h post-insult. Immunofluorescence of the ipsilateral white matter in the lipopolysaccharide (LPS) + hypoxic-ischemic (HI) group showed increased phospho-c-Jun N-terminal kinase (p-JNK) expression in (A) ED1-positive microglia, (B) RECA-positive endothelial cells and (C) O4-positive oligodendrocyte progenitors. Scale bar = 25 μm. Inset scale bar = 5 μm in (A), 10 μm in (B) and 2.5 μm in (C).
Figure 3 JNK activation in microglia, vascular endothelial cells and oligodendrocyte progenitors at 6 h post-insult. Immunofluorescence of the ipsilateral white matter in the lipopolysaccharide (LPS) + hypoxic-ischemic (HI) group showed increased phospho-c-Jun N-terminal kinase (p-JNK) expression in (A) ED1-positive microglia, (B) RECA-positive endothelial cells and (C) O4-positive oligodendrocyte progenitors. Scale bar = 25 μm. Inset scale bar = 5 μm in (A), 10 μm in (B) and 2.5 μm in (C).CC BY · PubMed Central
Figure 4 Activated microglia expressed p-JNK, p-c-Jun and TNF-α. Immunofluorescence of the ipsilateral white matter in the lipopolysaccharide (LPS) + hypoxic-ischemic (HI) group 24 h post-insult showed that ED1-positive activated microglia expressed phospho-c-Jun N-terminal kinases (p-JNK) (A) and TNF-α (C), and had nuclear translocation of p-c-Jun (B). Scale bar = 25 μm. Inset scale bar = 5 μm.
Figure 4 Activated microglia expressed p-JNK, p-c-Jun and TNF-α. Immunofluorescence of the ipsilateral white matter in the lipopolysaccharide (LPS) + hypoxic-ischemic (HI) group 24 h post-insult showed that ED1-positive activated microglia expressed phospho-c-Jun N-terminal kinases (p-JNK) (A) and TNF-α (C), and had nuclear translocation of p-c-Jun (B). Scale bar = 25 μm. Inset scale bar = 5 μm.CC BY · PubMed Central
Figure 5 JNK activation-mediated apoptosis in cerebral vascular endothelial cells and oligodendrocyte progenitors in the white matter after lipopolysaccharide-sensitized hypoxic-ischemia. Immunofluorescence of the lipopolysaccharide (LPS) + hypoxic-ischemic (HI) group 24 h post-insult showed numerous phospho-c-Jun N-terminal kinase (p-JNK)-positive cells attached to or located around the microvessels in the white matter (A). RECA-positive endothelial cells (A) and O4-positive oligodendrocyte progenitors (B) co-expressed p-JNK. Many p-JNK-positive cells (C), RECA-positive endothelial cells (D) and O4-positive oligodendrocyte progenitors (E) expressed cleaved caspase 3. Scale bar = 25 μm. Inset scale bar = 2.5 μm.
Figure 5 JNK activation-mediated apoptosis in cerebral vascular endothelial cells and oligodendrocyte progenitors in the white matter after lipopolysaccharide-sensitized hypoxic-ischemia. Immunofluorescence of the lipopolysaccharide (LPS) + hypoxic-ischemic (HI) group 24 h post-insult showed numerous phospho-c-Jun N-terminal kinase (p-JNK)-positive cells attached to or located around the microvessels in the white matter (A). RECA-positive endothelial cells (A) and O4-positive oligodendrocyte progenitors (B) co-expressed p-JNK. Many p-JNK-positive cells (C), RECA-positive endothelial cells (D) and O4-positive oligodendrocyte progenitors (E) expressed cleaved caspase 3. Scale bar = 25 μm. Inset scale bar = 2.5 μm.CC BY · PubMed Central
Figure 6 AS601245 significantly reduced neuroinflammation, blood–brain-barrier damage and cell apoptosis after lipopolysaccharide-sensitized hypoxic-ischemic white matter injury. (A) In vitro kinase assay of c-Jun N-terminal kinase (JNK) in the lipopolysaccharide (LPS) + hypoxic-ischemic (HI) group showed that AS601245 (40 mg/kg) effectively blocked JNK activity at 6 and 24 h post-insult compared with vehicle. (B) AS601245 (40 mg/kg) treatment (n = 8) significantly reduced upregulation of ED1-positive activated microglia, TNF-α immunoreactivities, IgG extravasation and cleaved caspase 3-positive cells in the white matter 24 h post-insult compared to vehicle (n = 7). Scale bar =100 μm for ED1, TNF-α and IgG; 50 μm for cleaved caspase 3. Values are means ± SEM. ***P <0.001, **P < 0.01, *P < 0.05.
Figure 6 AS601245 significantly reduced neuroinflammation, blood–brain-barrier damage and cell apoptosis after lipopolysaccharide-sensitized hypoxic-ischemic white matter injury. (A) In vitro kinase assay of c-Jun N-terminal kinase (JNK) in the lipopolysaccharide (LPS) + hypoxic-ischemic (HI) group showed that AS601245 (40 mg/kg) effectively blocked JNK activity at 6 and 24 h post-insult compared with vehicle. (B) AS601245 (40 mg/kg) treatment (n = 8) significantly reduced upregulation of ED1-positive activated microglia, TNF-α immunoreactivities, IgG extravasation and cleaved caspase 3-positive cells in the white matter 24 h post-insult compared to vehicle (n = 7). Scale bar =100 μm for ED1, TNF-α and IgG; 50 μm for cleaved caspase 3. Values are means ± SEM. ***P <0.001, **P < 0.01, *P < 0.05.CC BY · PubMed Central
Figure 7 AS601245 significantly reduced perivascular attachment of p-JNK-positive cells and cell apoptosis in the white matter 24 h post-insult. Immunofluorescent staining in the lipopolysaccharide (LPS) + hypoxic-ischemic (HI) group showed that, compared with vehicle, AS601245 (40 mg/kg) significantly attenuated perivascular phospho-c-Jun N-terminal kinase (p-JNK)-positive cell attachment (A), and also decreased cleaved caspase 3-positive endothelial (B) and oligodendroglial cells (C) in the white matter. Scale bar =25 μm.
Figure 7 AS601245 significantly reduced perivascular attachment of p-JNK-positive cells and cell apoptosis in the white matter 24 h post-insult. Immunofluorescent staining in the lipopolysaccharide (LPS) + hypoxic-ischemic (HI) group showed that, compared with vehicle, AS601245 (40 mg/kg) significantly attenuated perivascular phospho-c-Jun N-terminal kinase (p-JNK)-positive cell attachment (A), and also decreased cleaved caspase 3-positive endothelial (B) and oligodendroglial cells (C) in the white matter. Scale bar =25 μm.CC BY · PubMed Central
Figure 8 Pharmacological inhibition of c-Jun N-terminal kinase (JNK) activity using AS601245 significantly attenuated white matter injury. AS601245 (40 mg/kg) (n = 8) but not AS601245 (20 mg/kg) (n = 8) treatment had significantly higher myelin basic protein (MBP) (A) and lower glial fibrillary acidic protein (GFAP) (B) expression in the white matter than vehicle (n = 10) on P11 after lipopolysaccharide (LPS)-sensitized hypoxic-ischemia (HI) on P2. Scale bar = 200 μm in (A), 100 μm in (B). Values are means ± SEM. ***P < 0.001, **P < 0.01, *P < 0.05.
Figure 8 Pharmacological inhibition of c-Jun N-terminal kinase (JNK) activity using AS601245 significantly attenuated white matter injury. AS601245 (40 mg/kg) (n = 8) but not AS601245 (20 mg/kg) (n = 8) treatment had significantly higher myelin basic protein (MBP) (A) and lower glial fibrillary acidic protein (GFAP) (B) expression in the white matter than vehicle (n = 10) on P11 after lipopolysaccharide (LPS)-sensitized hypoxic-ischemia (HI) on P2. Scale bar = 200 μm in (A), 100 μm in (B). Values are means ± SEM. ***P < 0.001, **P < 0.01, *P < 0.05.CC BY · PubMed Central
Figure 9 JNK antisense oligodeoxynucleotide significantly reduced neuroinflammation, blood–brain-barrier damage and apoptosis in the white matter after lipopolysaccharide-sensitized hypoxic-ischemia. (A) Immunoblotting of the white matter showed that intracerebroventricular infusion of c-Jun N-terminal kinase (JNK) antisense oligodeoxynucleotides (ODN) (n = 3) effectively suppressed JNK expression compared with scrambled ODN (n = 3) at 3, 6 and 12 h post-insult. (B) Antisense ODN treatment (n = 8) significantly attenuated upregulation of ED1-positive activated microglia, TNF-α immunoreactivities, IgG extravasation and cleaved caspase 3-positive cells in the white matter 24 h post-insult compared with scrambled oligodeoxynucleotide (n = 8). Scale bar =100 μm for ED1, TNF-α and IgG; 50 μm for cleaved caspase 3. Values are means ± SEM. ***P < 0.001, **P < 0.01, *P < 0.05.
Figure 9 JNK antisense oligodeoxynucleotide significantly reduced neuroinflammation, blood–brain-barrier damage and apoptosis in the white matter after lipopolysaccharide-sensitized hypoxic-ischemia. (A) Immunoblotting of the white matter showed that intracerebroventricular infusion of c-Jun N-terminal kinase (JNK) antisense oligodeoxynucleotides (ODN) (n = 3) effectively suppressed JNK expression compared with scrambled ODN (n = 3) at 3, 6 and 12 h post-insult. (B) Antisense ODN treatment (n = 8) significantly attenuated upregulation of ED1-positive activated microglia, TNF-α immunoreactivities, IgG extravasation and cleaved caspase 3-positive cells in the white matter 24 h post-insult compared with scrambled oligodeoxynucleotide (n = 8). Scale bar =100 μm for ED1, TNF-α and IgG; 50 μm for cleaved caspase 3. Values are means ± SEM. ***P < 0.001, **P < 0.01, *P < 0.05.CC BY · PubMed Central
Figure 10 c-Jun N-terminal kinase (JNK) antisense oligodeoxynucleotide significantly attenuated white matter injury. Antisense oligodeoxynucleotide (ODN) treatment (n = 8) markedly increased myelin basic protein (MBP) (A) and decreased glial fibrillary acidic protein (GFAP) (B) expression in the white matter compared with scrambled ODN (n = 8) on P11 after lipopolysaccharide (LPS)-sensitized hypoxic-ischemia (HI) on P2. Scale bar = 200 μm in (A), 100 μm in (B). Values are means ± SEM. ***P < 0.001, *P < 0.05.
Figure 10 c-Jun N-terminal kinase (JNK) antisense oligodeoxynucleotide significantly attenuated white matter injury. Antisense oligodeoxynucleotide (ODN) treatment (n = 8) markedly increased myelin basic protein (MBP) (A) and decreased glial fibrillary acidic protein (GFAP) (B) expression in the white matter compared with scrambled ODN (n = 8) on P11 after lipopolysaccharide (LPS)-sensitized hypoxic-ischemia (HI) on P2. Scale bar = 200 μm in (A), 100 μm in (B). Values are means ± SEM. ***P < 0.001, *P < 0.05.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

Sorted by citations

See all 119

Related

See all

Metadata

Authors
Wang, L.-W., Tu, Y.-F., Huang, C.-C., & Ho, C.-J.
Affiliations
National Cheng Kung University (TW)
Corresponding author
Huang, Chao-Ching
ORCID
Venue
Journal of Neuroinflammation
Publisher
Springer Science and Business Media LLC
Published
2012-07-17
Volume
9
Issue
1
Pages
175-175
ISSN
1742-2094 (ISSN-L)
DOI
10.1186/1742-2094-9-175
PMC
PMC3414763
OpenAlex
W1971748792
Cited by
119
References
72
Citations by year
2026: 4 · 2025: 8 · 2024: 6 · 2023: 7 · 2022: 5 · 2021: 11 · 2020: 8 · 2019: 9 · 2018: 10 · 2017: 10 · 2016: 11 · 2015: 11 · 2014: 8 · 2013: 9 · 2012: 1
FWCI
8.15
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Neuroinflammation (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • National Science Council
  • National Health Research Institutes
  • Chi Mei Medical Center
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and fetal brain pathology
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
Keywords
JNK signaling, white matter injury, neuroinflammation, blood-brain barrier disruption, hypoxia-ischemia, preterm infants, microglial activation, TNF-α, IgG extravasation, JNK inhibition, oligodeoxynucleotides
MeSH terms
Animals, Animals, Newborn, Blood-Brain Barrier, Brain, Inflammation, Nerve Fibers, Myelinated, Oligodendroglia, Rats, Sprague-Dawley, Apoptosis, Hypoxia-Ischemia, Brain, MAP Kinase Signaling System, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review